雅思大作文：research into new types of medicine and treatments are essential
雅思大作文题目：Research into new types of medicine and treatments are essential for improving health and deal with diseases. Who do you think should fund these researches: private companies, individuals or governments?
Give reasons for your answer and include any relevant examples from your own knowledge or experience.
Medical advancement like new drugs and therapies have been improving the average longevity of citizens and both their phyical and mental well-being, so a massive amount of funds have been and would be continously poured into this field. This essay discusses whether the fundings should originate from ordinary people, major coporations or governments.
Individuals, or the general public to be precise, perform little in medical progress. This fact should be widely acknowledged although this group is the major one that enjoys the achievements on health care. That is mainly because any one kind of new medicines requires time and money that is way beyond any single citizens affordability compared with the other two parities mentioned.
Business markets, in comparison, play a vital role on this issue. Businessmen can better detect and meet the needs of people patients in this context and they are able to invest greater capital in the pursuing latter higher profits. This strong incentive can bring along fresh treatments and a series of new drugs in the short term. However, the patented medical products with high prices can inflict greater pain for the lower class, which is the root of growing health disparities in the global context. Simply put, health care should not be regarded as a commercial activity but a social obligation.
Governments should take over this mission and cover the most costs. Their obligations, a well-argued and decided issue, are to organize social assets and to invest into fields that benefit people amid the general development. Moreover, the authority occupying greater statistical resources can better decide in which particular disease or diseases should the fundings be invested to help the majority or the immediate. Yet, it is to admit that tax revenue for these scientific researches may be ended up in vain as all the progress have based on numerous failures.
To sum up, I believe that major global companies and governments can both be the main investors on these projects whereas some tradeoffs can be implemented to benefit virtually all citizens, like regulation on price fixing and supervision on the distribution of government fundings.